Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)

  1. Vukusic, S.
  2. Brassat, D.
  3. de Seze, J.
  4. Izquierdo, G.
  5. Lysandropoulos, A.
  6. Moll, W.
  7. Vanopdenbosch, L.
  8. Arque, M.J.
  9. Kertous, M.
  10. Rufi, P.
  11. Oreja-Guevara, C.
Aldizkaria:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356,  2211-0348

Argitalpen urtea: 2019

Alea: 29

Orrialdeak: 7-14

Mota: Artikulua

DOI: 10.1016/J.MSARD.2019.01.019 GOOGLE SCHOLAR
Datuen iturria: Scopus